{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Ioflubenzamide_I-131",
  "nciThesaurus": {
    "casRegistry": "1214283-52-9",
    "chebiId": "",
    "chemicalFormula": "C21H25FIN3O3",
    "definition": "An iodine 131-radiolabeled small-molecule benzamide compound with potential antineoplastic activity. The benzamide moiety of 131-I-MIP-1145 binds to melanin, selectively delivering a cyotoxic dose of gamma and beta radiation to melanin-expressing tumor cells. Melanin pigments, polymer derivatives of the amino acid tyrosine, are over-expressed in approximately 40% of melanomas.",
    "fdaUniiCode": "65O1D58Z6V",
    "identifier": "C80056",
    "preferredName": "Ioflubenzamide I-131",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C2124"
    ],
    "synonyms": [
      "IOFLUBENZAMIDE I-131",
      "Ioflubenzamide (131I)",
      "Ioflubenzamide I-131",
      "MIP-1145",
      "N-(2-(diethylamino)ethyl)-4-((4-fluorobenzoyl)amino)-5-((sup 131)I)iodo-2-methoxybenzamide"
    ]
  }
}